Habib J. Dable - 10 Jul 2023 Form 4 Insider Report for Aerovate Therapeutics, Inc. (JBIO)

Role
Director
Signature
/s/ George A. Eldridge, Attorney-in-Fact
Issuer symbol
JBIO
Transactions as of
10 Jul 2023
Net transactions value
$0
Form type
4
Filing time
11 Jul 2023, 17:06:39 UTC
Previous filing
26 Jun 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTE Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 10 Jul 2023 Common Stock 25,000 $18.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on August 10, 2023.